Skip to content

Are You Covered? A Liability Insurance Primer for Compounders | Essential: The Pharmacy Compounding Podcast

Pharmacy Podcast Network

30m
Transcript

Original podcast

Where to listen

Summary

Written by a model from the transcript; not yet reviewed.

This episode covers key legal, regulatory, and business developments for compounding pharmacies, focusing on liability insurance. The host, Andrew Cantor, shares legislative updates, including the death of an anti-compounding bill in California and modifications to the federal Safe Drugs Act, alongside looming FDA guidance on natural thyroid medications and peptides. In the main segment, Scott Brunner speaks with Kristen Jones, Associate Vice President at Pharmacist Mutual Insurance Company, about the unique liability risks compounding pharmacies face compared to traditional retail dispensers. They discuss how ingredients, calculations, sterility, volume, and new business models like telehealth impact insurance coverage and why owners must communicate operational changes to their agents.

  • Review your insurance coverage with your agent regularly, especially when adding new equipment or business operations. 28:07
  • Notify your insurance claims department immediately if you receive a state board letter or patient complaint. 23:56
  • Focus on ingredient selection and calculation accuracy, as these account for nearly half of compounding errors. 11:03
  • Recognize that having a valid prescription from a prescriber does not eliminate a pharmacist's independent professional liability. 25:00

Chapters

  1. 0:05
    Podcast Intro and Compounding News

    Hosts introduce the episode, give a quick compounding news update, and preview the main interview.

  2. 0:52
    California Anti-Compounding Bill Dies

    Andrew reports that the California anti-compounding bill AB 1990 has quietly died, sparing compounding pharmacies from new restrictions.

  3. 2:00
    Federal Safe Drugs Act Revisions

    Discussion of the Safe Drugs Act, its revisions, and how it now allows shortage drug compounding and requires MedWatch reporting.

  4. 3:11
    Biologics Status of Thyroid Meds

    Explains FDA’s classification of animal-derived thyroid meds as biologics, limiting compounding and affecting patient options.

  5. 5:25
    Peptide Compounding Outlook

    Overview of FDA PCAC recommendations for peptides, uncertainty about implementation, and potential impact on compounding pharmacies.

  6. 9:34
    Risk Profile of Compounding vs Dispensing

    Kristen explains how compounding creates a higher risk profile due to formulation responsibility and potential for batch errors.

  7. 12:01
    Sterile vs Non‑Sterile Coverage

    Details how Pharmacist Mutual handles sterile compounding endorsements, premium differences, and underwriting practices.

  8. 15:32
    Common Misunderstandings About Coverage

    Kristen lists typical owner misconceptions, emphasizes communication with agents, and covers equipment, business interruption, and employment liability.

  9. 17:50
    GLP‑1 and Telehealth Risks

    Discussion of compounded GLP‑1 drugs, telehealth contracts, and how these new activities affect insurance underwriting and risk.

  10. 20:41
    Coverage Limits for Unapproved Substances

    Kristen explains that insurance does not cover activities outside legal or regulatory frameworks and advises caution before compounding unapproved drugs.

  11. 22:48
    Reporting and Notification Requirements

    Outlines when pharmacy owners should notify insurers about FDA letters, state board actions, or patient complaints to maintain coverage.

  12. 27:52
    Lightning Round: Three Key Steps

    Kristen gives a concise checklist for owners: insurance checkup, operational risk control, and open communication with agents.

Highlights

  • 9:46

    Compounding Liability Differencesinsight

    The guest explains that unlike retail dispensaries that sell pre-manufactured drugs, compounding pharmacies take on manufacturing responsibilities, meaning a single calculation or ingredient error can affect multiple patients.

  • 11:03

    Calculations Over Sterilitydata

    Data shows that calculation and ingredient selection errors contribute to nearly half of compounding sector errors, whereas sterile compounding claims are less frequent though more severe.

  • 13:27

    Sterile Compounding Endorsementsstrategy

    Professional liability policies do not automatically cover sterile compounding; pharmacies must obtain an extra endorsement and pay additional premium due to the higher risk profile.

  • 16:54

    Clean Room Incident Storystory

    The guest shares an example where a perpetrator cut through a wall into a clean room, knocking it down for months and illustrating the importance of business interruption insurance.

  • 20:54

    Unapproved Substances Coverageinsight

    The guest warns that insurance policies are not safety nets for illegal activities, meaning compounding substances outside federal or state law may result in coverage denials.

  • 23:32

    Filing Notice Only Claimsstrategy

    Unlike homeowners insurance where filing claims might raise rates, professional liability carriers evaluate notice-only potential claims differently, so getting insurers involved early is encouraged.

Quotes

  • “AB 1990, that's the bill's number.”
    Unnamed speaker · 0:59
  • “With compounding, the pharmacy becomes part of the manufacturing process itself.”
    Unnamed speaker · 9:46
  • “If you are compounding a substance that's not legally permitted under either federal or state law, you may have coverage issues that arise depending on the facts, policy language, and circumstances involved if there is a claim that's filed.”
    Unnamed speaker · 21:04
  • “The fact that a prescription, you have a prescription in your hand, doesn't eliminate your obligation to evaluate whether that therapy is appropriate, if the compounded preparation is legal, and whether it's prepared safely and accurately.”
    Unnamed speaker · 25:17
  • APC 30:06–30:34

About this episode

This episode looks at some smart ways to regulate pharmacy when it comes to med spas and pop-up clinics — ways that won’t cut patients off from their meds. We also look at the latest news on the thyroid-extract front, what’s happening with peptide compounding, and a bill in California that could bode well for pharmacists nationwide. Then we talk with Kristen Jones, PharmD, from Pharmacists Mutual about how insurance companies view compounding, and why compounders are taking a bigger risk than they might realize if they’re compounding peptides. Pharmacists Mutual: https://pmuw.comJoin APC: a4pc.org/joinStay up to date on these topics and more at: a4pc.org/news

Transcript

0:00
30:46

5,080 words · 4 speakers

Topics

  • FDA
  • peptides
  • GLP-1s
  • California
  • PCAC
  • Telehealth
  • Pharmacy Podcast Network
  • Essential Pharmacy Compounding News
  • Alliance for Pharmacy Compounding
  • Pharmacist Mutual Insurance Company

Page updated · transcript and summary are machine-generated